Syngene International ropes in Yogesh Pandey as Talent Acquisition Lead Ruchika Sharma25 April 2025 3:23 PM ISTKarnataka: Syngene International Limited has appointed Yogesh Pandey as Talent Acquisition Lead in the Company.In a recent LinkedIn...
Priyadarshini Mahapatra to exit Syngene International as Head Legal, Company Secretary & Compliance Officer Ruchika Sharma24 April 2025 2:46 PM ISTKarnataka: Syngene International Limited, a listed subsidiary of Biocon Limited, has announced the resignation of Priyadarshini...
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions Ruchika Sharma20 March 2025 2:30 PM ISTBengaluru: Syngene International Limited has announced the conclusion of the acquisition of its first biologics site in the USA, which was announced...
Syngene buys its first manufacturing facility in US for USD36.5 million Ruchika Sharma11 March 2025 12:39 PM ISTBangalore: Syngene International Limited, a global contract research, development, and manufacturing organization (CRDMO), has acquired its first...
Syngene International gets 5 USFDA observations for Bengaluru facilities Ruchika Sharma24 Feb 2025 11:30 AM ISTBengaluru: Syngene International has announced that the U.S. Food and Drugs Administration (USFDA) has concluded the inspection with five...
Syngene International: Peter Bains returns as CEO, Jonathan Hunt steps down Ruchika Sharma11 Feb 2025 12:31 PM ISTBangalore: Syngene International Limited has announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the...
Dr Sridevi Khambhampaty appointed as CEO of Shilpa Biologicals Ruchika Sharma20 Sept 2024 11:30 AM ISTKarnataka: Shilpa Medicare has announced the appointment of Dr Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals...
Syngene unveils platform for rapid, enhanced protein production Ruchika Sharma6 Jun 2024 1:30 PM ISTSan Diego: A global contract research, development and manufacturing organization (CRDMO), Syngene International Ltd., has announced...
Evaluate safety in proposed study: CDSCO Panel tells Syngene on Suplatast Tosilate Capsule Dr. Divya Colin7 Oct 2023 6:00 PM ISTNew Delhi: Approving the proposal presented by Syngene International to conduct a Phase II clinical trial of Suplatast Tosilate 100mg Capsule, the...
Submit Revised protocol for Torsemide ER tablets: CDSCO Tells Syngene Dr. Divya Colin19 July 2023 6:00 PM ISTNew Delhi: Highlighting that proof of concept and criteria are not defined for the overactive bladder in Congestive heart failure (CHF) patients, the...
Strides Pharma Science biologics arm to divest Unit 3 multi modal facility to Syngene International for Rs 702 crore Ruchika Sharma5 July 2023 12:30 PM ISTBengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm...
USFDA successfully concludes inspection at Syngene Bangalore facility Ruchika Sharma16 Nov 2022 3:30 PM ISTBengaluru: Syngene International Limited has recently announced that the US Food Drug Administration (USFDA) has successfully concluded a pre-approval...
